I-SARS-CoV-2Antigen Rapid Test Kit (TRFIA) iwukuhlola isangweji le-immunofluorescent. Ukutholwa kwe-SARS-CoV-2 nucleocapsid protein antigen kungasetshenziswa ukusiza ukuhlonza ukutheleleka ngegciwane le-corona, futhi kuyasiza ekutholweni kwenoveli kusenesikhathi. i-corona virus pneumonia infection in the latent period.Umucu wokuhlola uqukethe ulwelwesi olumbozwe ngaphambili ngamasosha omzimba egundane e-anti-CoV N amaprotheni emigqeni yokuhlola.Lapho isampula lisetshenziswa emithonjeni yesampula, kwakheka amaprotheni e-SARS-CoV N nama-antibody complexes anelebula futhi akhuphuke ngomugqa.I-microsphere fluorescent probe reagent enelebula isetshenziselwa ukwenza ulayini obomvu obonakalayo onethoshi le-UV elifaniswe.Ukuba khona kwe-SARS-CoV-2 kuzobonakala ngomugqa wokuhlola obomvu obonakalayo (T) efasiteleni lemiphumela.I-Membrane imbozwe ngaphambili ngeChicken IgY kulayini wokulawula(C).Ulayini wokulawula(C) uvela ewindini ngalinye lomphumela lapho isampula ligeleza emgqeni.Ulayini Wokulawula usetshenziswa njengokulawula inqubo.Ulayini wokulawula kufanele uhlale uvela lapho inqubo yokuhlola yenziwa kahle futhi ama-reagents asebenza ngendlela ehlosiwe.Ukuhlolwa kwe-antigen okusheshayo kuyithuluzi lokuxilonga, kodwa akuhloselwe ukuqinisekisa ukutheleleka okusebenzayo noma ukuvimbela ukusulelana phakathi kwabantu abangenazo izimpawu.Zenzelwe abantu abanezimpawu ze-COVID-19, abantu abasondelene kakhulu necala le-COVID eliqinisekisiwe, kanye nokulandelela abantu abayingxenye yokugqashuka.